Bioavailability of Tebipenem (SPR994) Crushed Tablet

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

June 1, 2022

Study Completion Date

December 23, 2022

Conditions

Relative Bioavailability

Interventions

DRUG

Tebipenem tablet form

Tebipenem tablets will be administered intact or crushed

OTHER

Tube feeds

Tebipenem tablets will be administered with or without tube feeds

Trial Locations (1)

Hartford Hospital, Hartford